
Australia's Genesis makes biolabs investment

Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
The size of the deal was not disclosed. It comes from Genesis’ debut fund – one of few dedicated healthcare private equity vehicles operating in the local market – which closed on AUD 190m (USD 142m)...
Latest News
Asia IPOs gone cold: India edition
A compilation of India-based IPOs - some of them private equity-backed - that have been withdrawn or appear to have fallen behind schedule
China LiDAR specialist Hesai aims for US IPO
Hesai Technology, a China-based developer of sensors used in autonomous driving, is targeting a US listing. Its investors include Lightspeed China Partners, Baidu, Bosch, and Xiaomi.
Indonesia fintech start-up iSeller gets $12m
Indonesia financial technology start-up iSeller, which helps businesses to digitise sales and operations, has raised USD 12m in Series B funding led by Intudo Ventures.
Hillhouse-backed China pet services business seeks US listing
New Ruipeng Pet Group, a China-based pet care services platform that counts Hillhouse Capital as a significant shareholder, has filed for an IPO in the US.